MCO
68
-2
SNA
53
3
ISRG
69
-2
FAST
37
7
DOW
52
5
IBM
65
4
D
37
4
ORLY
45
5
BMY
68
-3
MTCH
62
-15
CHD
27
4
DHI
48
7
WDC
57
-7
PM
60
8
NOC
63
2
WM
60
3
NUE
64
3
WU
54
2
TAP
24
-5
SYY
50
11
MCO
68
-2
SNA
53
3
ISRG
69
-2
FAST
37
7
DOW
52
5
IBM
65
4
D
37
4
ORLY
45
5
BMY
68
-3
MTCH
62
-15
CHD
27
4
DHI
48
7
WDC
57
-7
PM
60
8
NOC
63
2
WM
60
3
NUE
64
3
WU
54
2
TAP
24
-5
SYY
50
11
Financhill
Back

NovaBay Pharmaceuticals, Inc. Vs. Crinetics Pharmaceuticals, Inc. Industry Stock Comparison

Buy
84

NBY
NovaBay Pharmaceuticals, Inc.

Last Price:
$19.26
Seasonality Move:
5.22%
Sell
34

CRNX
Crinetics Pharmaceuticals, Inc.

Last Price:
$53.24
Seasonality Move:
-11.9%
Buy
84
NovaBay Pharmaceuticals, Inc. (NBY) is a Buy

Is NovaBay Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals, Inc. [NBY] share price is $9.46. The Score for NBY is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
  • NBY is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
34
Crinetics Pharmaceuticals, Inc. (CRNX) is a Sell

Is Crinetics Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $53.24. The Score for CRNX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals, Inc.'s stock price today?

  • The NovaBay Pharmaceuticals, Inc. share price today is $9.46
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing slight selling pressure.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals, Inc.'s stock price today?

  • The Crinetics Pharmaceuticals, Inc. share price today is $53.24
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing slight selling pressure.

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.8 Buy
Relative Strength Index (14 RSI): 75.95 Buy
Chaikin Money Flow: -303689 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.63 - 6.69) Buy
Bollinger Bands (100): (0.33 - 3.97) Buy

CRNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.28 Buy
Relative Strength Index (14 RSI): 65.68 Buy
Chaikin Money Flow: -209678 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.25 - 50.15) Buy
Bollinger Bands (100): (35.32 - 47.44) Buy

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.97 Buy
20-day SMA: 4.9 Buy
50-day SMA: 2.62 Buy
200-day SMA: 1.37 Buy
8-day EMA: 7.47 Buy
20-day EMA: 5.43 Buy
50-day EMA: 3.39 Buy
200-day EMA: 1.26 Buy

CRNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.77 Buy
20-day SMA: 48.57 Buy
50-day SMA: 45.67 Buy
200-day SMA: 36.1 Buy
8-day EMA: 49.69 Buy
20-day EMA: 48.35 Buy
50-day EMA: 45.87 Buy
200-day EMA: 40.28 Buy

NovaBay Pharmaceuticals, Inc. Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and a decrease next year of $0.00 per share.

Crinetics Pharmaceuticals, Inc. Earnings Growth & CRNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $1.51 per share.

NovaBay Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):